These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11013236)
1. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. Citron BA; SantaCruz KS; Davies PJ; Festoff BW J Biol Chem; 2001 Feb; 276(5):3295-301. PubMed ID: 11013236 [TBL] [Abstract][Full Text] [Related]
2. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Citron BA; Suo Z; SantaCruz K; Davies PJ; Qin F; Festoff BW Neurochem Int; 2002 Jan; 40(1):69-78. PubMed ID: 11738473 [TBL] [Abstract][Full Text] [Related]
3. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. Festoff BW; SantaCruz K; Arnold PM; Sebastian CT; Davies PJ; Citron BA J Neurochem; 2002 May; 81(4):708-18. PubMed ID: 12065630 [TBL] [Abstract][Full Text] [Related]
4. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Ingelsson M; Ramasamy K; Cantuti-Castelvetri I; Skoglund L; Matsui T; Orne J; Kowa H; Raju S; Vanderburg CR; Augustinack JC; de Silva R; Lees AJ; Lannfelt L; Growdon JH; Frosch MP; Standaert DG; Irizarry MC; Hyman BT Acta Neuropathol; 2006 Oct; 112(4):439-49. PubMed ID: 16802167 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. Kim SY; Grant P; Lee JH; Pant HC; Steinert PM J Biol Chem; 1999 Oct; 274(43):30715-21. PubMed ID: 10521460 [TBL] [Abstract][Full Text] [Related]
7. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Zhang J; Wang S; Huang W; Bennett DA; Dickson DW; Wang D; Wang R Mol Neurobiol; 2016 Oct; 53(8):5066-78. PubMed ID: 26386840 [TBL] [Abstract][Full Text] [Related]
8. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011 [TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase during mouse central nervous system development: lack of alternative RNA processing and implications for its role(s) in murine models of neurotrauma and neurodegeneration. Citron BA; Zoloty JE; Suo Z; Festoff BW Brain Res Mol Brain Res; 2005 Apr; 135(1-2):122-33. PubMed ID: 15857675 [TBL] [Abstract][Full Text] [Related]
10. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. Boutajangout A; Boom A; Leroy K; Brion JP FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the dual function tissue transglutaminase/Galpha(h) during murine neuromuscular development: gene and enzyme isoform expression. Citron BA; Gregory EJ; Steigerwalt DS; Qin F; Festoff BW Neurochem Int; 2000 Oct; 37(4):337-49. PubMed ID: 10825574 [TBL] [Abstract][Full Text] [Related]
12. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures. Appelt DM; Balin BJ Brain Res; 1997 Jan; 745(1-2):21-31. PubMed ID: 9037390 [TBL] [Abstract][Full Text] [Related]
13. Possible roles of transglutaminases in Alzheimer's disease. Yamada T; Yoshiyama Y; Kawaguchi N; Ichinose A; Iwaki T; Hirose S; Jefferies WA Dement Geriatr Cogn Disord; 1998; 9(2):103-10. PubMed ID: 9524802 [TBL] [Abstract][Full Text] [Related]
14. Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. Tucholski J; Kuret J; Johnson GV J Neurochem; 1999 Nov; 73(5):1871-80. PubMed ID: 10537045 [TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target. Wilhelmus MM; de Jager M; Bakker EN; Drukarch B J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636 [TBL] [Abstract][Full Text] [Related]
16. Tau and saitohin gene expression pattern in progressive supranuclear palsy. Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831 [TBL] [Abstract][Full Text] [Related]
17. Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. Lai TS; Liu Y; Li W; Greenberg CS FASEB J; 2007 Dec; 21(14):4131-43. PubMed ID: 17609251 [TBL] [Abstract][Full Text] [Related]
18. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. Wang DS; Uchikado H; Bennett DA; Schneider JA; Mufson EJ; Wu J; Dickson DW J Alzheimers Dis; 2008 Feb; 13(1):53-66. PubMed ID: 18334757 [TBL] [Abstract][Full Text] [Related]
19. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Norlund MA; Lee JM; Zainelli GM; Muma NA Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839 [TBL] [Abstract][Full Text] [Related]
20. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy. Zemaitaitis MO; Kim SY; Halverson RA; Troncoso JC; Lee JM; Muma NA J Neuropathol Exp Neurol; 2003 Feb; 62(2):173-84. PubMed ID: 12578227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]